US2020229456A1PendingUtilityA1

Synergistic Formulation Including At Least One Gibberellin Compound and Salicyclic Acid

56
Assignee: STOLLER ETSPriority: Apr 30, 2018Filed: Apr 8, 2020Published: Jul 23, 2020
Est. expiryApr 30, 2038(~11.8 yrs left)· nominal 20-yr term from priority
A23B 2/754A23B 2/742A23B 2/771A23B 7/16A23B 7/154A23B 7/152A01N 45/02A01N 43/16A23L 3/3508A23L 3/3544
56
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A synergistic formulation comprising at least one gibberellin (GA) compound and salicylic acid (SA) for delaying fruit ripening and maintaining good quality of fruit under storage.

Claims

exact text as granted — not AI-modified
We claim: 
     
         1 . A synergistic formulation comprising,
 at least one gibberellin (GA) compound;   at least 0.00625 wt. % salicylic acid (SA);   ≥50 wt. % at least one organic solvent;   less than 5 wt. % water;   optionally at least one non-ionic or anionic surfactants; and   optionally at least one adjuvant,   wherein said formulation includes more GA than SA based on the total weight of the formulation.   
     
     
         2 . The synergistic formulation of  claim 1  comprising,
 up to 20 wt. % of said at least one gibberellin (GA) compound, and 
 0.00625 to 19 wt. % salicylic acid (SA). 
 
     
     
         3 . The synergistic formulation of  claim 1  comprising,
 18-20 wt. % of said at least one gibberellin (GA) compound; and 50-62 wt. % of said at least one organic solvent based on the total weight of the formulation. 
 
     
     
         4 . The synergistic formulation of  claim 1  comprising,
 5-18.2 wt. % of said at least one gibberellin (GA) compound; 0.9-5 salicylic acid (SA); and 75-84 wt. % of said at least one organic solvent based on the total weight of the formulation. 
 
     
     
         5 . The synergistic formulation of  claim 1  comprising,
 18-20 wt. % of said at least one gibberellin (GA) compound; 0.5-1 wt. % salicylic acid (SA); and 75-81.5 wt. % of said at least one organic solvent based on the total weight of the formulation. 
 
     
     
         6 . The synergistic formulation of  claim 1  comprising,
 about 12 wt. % of said at least one gibberellin (GA) compound; about 4.5 wt. % salicylic acid (SA); and 80-83 wt. % of said at least one organic solvent based on the total weight of the formulation. 
 
     
     
         7 . The synergistic formulation of  claim 1  wherein said at least one gibberellin compound and said salicylic acid are the only active agents in said formulation. 
     
     
         8 . The synergistic formulation of  claim 1  wherein no halogenated compounds are present in said formulation. 
     
     
         9 . The synergistic formulation of  claim 8  wherein no CaCl 2  is present in said formulation. 
     
     
         10 . The synergistic formulation of  claim 1 , wherein said gibberellin compound is selected from the group consisting of gibberellic acid (“GA 3 ”), gibberellin 4  (“GA 4 ”), gibberellin4/7 (“GA 4/7 ”), and combinations thereof. 
     
     
         11 . The synergistic formulation of  claim 10  wherein said gibberellin compound is gibberellic acid (“GA 3 ”). 
     
     
         12 . The synergistic formulation of  claim 1 , wherein said at least one organic solvent is selected from the group consisting of alcohols, dialkyl ketones, alkylene carbonates, alkyl esters, pyrrolidones, aryl esters, and combinations thereof. 
     
     
         13 . The synergistic formulation of  claim 1 , wherein said at least one organic solvent is selected from the group consisting of ethanol, n-propanol, iso-propanol, ethyl lactate, 3-hydroxybutyrate (ethyl and propyl esters), polymeric and non-polymeric glycols, glycerols, polyethylene glycol, polypropylene glycol, propylene carbonate and combinations thereof. 
     
     
         14 . The synergistic formulation of  claim 1 , wherein said at least one organic solvent is propylene glycol. 
     
     
         15 . The synergistic formulation of  claim 1 , wherein said at least one organic solvent is at least one polyethylene glycol (PEG) with a molecular weight from 190-420. 
     
     
         16 . The synergistic formulation of  claim 1  comprising ≤10 wt. % of said at least one non-ionic or anionic surfactants based on the total weight of the formulation. 
     
     
         17 . The synergistic formulation of  claims 1  comprising less than 10 wt. % of said at least one adjuvant based on the total weight of the synergistic formulation. 
     
     
         18 . A synergistic formulation consisting essentially of,
 up to 20 wt. % at least one gibberellin (GA) compound based on the total weight of the formulation;   0.00625 to 19 wt. % salicylic acid (SA) based on the total weight of the formulation;   at least 50 wt. % at least one organic solvent based on the total weight of the formulation;   less than 5 wt. % water based on the total weight of the formulation;   less than 10 wt. % at least one additional component;   ≤10 wt. % at least one non-ionic or anionic surfactants based on the total weight of the formulation;   ≤10 wt. % at least one adjuvant based on the total weight of the formulation,   wherein said formulation includes more GA than SA based on the total weight of the formulation.   
     
     
         19 . A synergistic formulation consisting of,
 up to 20 wt. % at least one gibberellin (GA) compound based on the total weight of the formulation;   0.00625 to 19 wt. % salicylic acid (SA) based on the total weight of the formulation;   at least 50 wt. % at least one organic solvent based on the total weight of the formulation;   less than 5 wt. % water based on the total weight of the formulation;   less than 10 wt. % at least one additional component selected from the group consisting of surface active agents, crystal growth inhibitors, fungicides, stickers, spreaders, leaf penetrants, dispersants, systemic acquired resistance inducers, systemic acquired resistance inhibiters, anti-foaming agents, preservatives, pH regulators, cosolvents, humectants, dyes, UV protectants, vehicles, sequestrants, and combinations thereof,   ≤10 wt. % at least one non-ionic or anionic surfactants based on the total weight of the formulation;   ≤10 wt. % at least one adjuvant based on the total weight of the formulation   wherein said formulation includes more GA than SA based on the total weight of the formulation.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.